This webinar will explore the evolving role of liver transplantation in the treatment of cancer. As transplant oncology rapidly develops, new indications are being introduced for patients with neuroendocrine tumors (NETs), colorectal liver metastases, and cholangiocarcinoma. Our panel of experts will discuss the clinical evidence, evolving guidelines, and practical considerations in patient selection and management — as well as where the field is heading.
Session Highlights:
Historical evolution and expanding indications in transplant oncology
Neuroendocrine tumors: indications, controversies, and outcomes
Cholangiocarcinoma in the setting of PSC: from evidence to practice
Colorectal liver metastases: when is transplant an option?
Future directions: balancing immunotherapy and immunosuppression in oncology
Open panel discussion and live audience Q&A
Meet the Speakers:
Dr Tahir Shah - Consultant Hepatologist, Queen Elizabeth Hospital Birmingham
Dr Shah is an experienced liver specialist with deep expertise in managing complex hepatobiliary and transplant patients. His academic and clinical interests span hepatocellular carcinoma, cholangiocarcinoma, and transplant eligibility. He brings a hepatologist’s perspective on oncologic indications for transplantation and the long-term management of these patients.
Mr Bobby Dasari - Consultant HPB and Transplant Surgeon, Queen Elizabeth Hospital Birmingham
Mr Dasari is a senior transplant and hepatobiliary surgeon with a track record in complex liver and pancreas surgery. He has been involved in national work on transplant oncology and is known for his role in expanding surgical eligibility criteria for patients with oncological diagnoses. His insights will span both surgical innovation and service delivery in the transplant setting.
Dr Shivan Sivakumar - Associate Professor in Oncology and Honorary Consultant in Medical Oncology, University of Birmingham
Dr Sivakumar is a leading researcher and clinician in liver oncology, with a special focus on neuroendocrine tumors, immunotherapy, and the interface between cancer biology and transplantation. His research informs policy and practice around systemic therapy in transplant candidates, making him an ideal voice for bridging oncology and transplantation.
Webinar Link: bit.ly/herricksociety
Spots are limited — don’t miss this opportunity to learn, ask questions, and shape the future of transplantation.